Show simple item record

dc.contributor.authorCordero Pérez, Francisco Josué
dc.contributor.authorMartínez Rodríguez, Pablo
dc.contributor.authorArribas-Pérez, Luis
dc.contributor.authorPuertas Miranda, David
dc.contributor.authorPires-Baltazar, Carlos-Rafael
dc.contributor.authorSalcedo-Martín, Leticia
dc.contributor.authorSánchez-Villoria, Juan Antonio
dc.contributor.authorDíaz-Ávila, Erik Gabriel
dc.contributor.authorTernavasio de la Vega, Hugo Guillermo
dc.contributor.authorMarcos Martín, Miguel 
dc.contributor.authorChamorro Fernández, Antonio Javier 
dc.date.accessioned2025-12-11T09:00:01Z
dc.date.available2025-12-11T09:00:01Z
dc.date.issued2025-08-29
dc.identifier.citationCordero-Pérez, F.-J., Martínez-Rodríguez, P., Arribas-Pérez, L., Puertas-Miranda, D., Pires-Baltazar, C.-R., Salcedo-Martín, L., Sánchez-Villoria, J. A., Díaz-Ávila, E. G., Ternavasio-De La Vega, H.-G., Marcos, M., & Chamorro, A.-J. (2025). [Rev. of Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain’s National Health Data (2016–2022)]. Autoimmunity Reviews, 24(9). https://doi.org/10.1016/J.AUTREV.2025.103863es_ES
dc.identifier.issn1568-9972
dc.identifier.urihttp://hdl.handle.net/10366/168217
dc.description.abstract[EN]ANCA-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), is a systemic autoimmune disease. This study represents the first large-scale analysis of AAV hospitalisation rates and in-hospital mortality trends in Spain. A retrospective longitudinal analysis of AAV-related hospital admissions between 2016 and 2022 was conducted using the ICD-10 codes from the Minimum Basic Dataset (MBDS) of the Spanish National Health System. Statistical analyses were performed, including odds ratios, Student's t-tests, and Mantel-Haenszel trend tests. Among 5753 AAV episodes, GPA was the most frequent subtype (53.9 %), followed by MPA (31.5 %) and EGPA (14.6 %). AAV episodes were more frequent in older patients (> 65 years) than in other hospital episodes (62.9 % vs. 38.9 %; OR: 2.66, 95 %CI: 2.51-2.80; P < 0.001). Larger hospitals accounted for more AAV episodes, longer hospital stays, and higher costs. MPA had the highest mortality rate (7.2 % vs. 4.9 %; OR: 1.52, 95 % CI: 1.27-1.79; P < 0.001), particularly in patients over 65 years (83.1 % vs. 61.8 %; OR: 3.04, 95 % CI: 2.47-3.75; P < 0.001) compared with the other AAV. In the GPA group, renal involvement significantly increased mortality compared to GPA cases without renal involvement (6.6 % vs. 4.6 %; OR: 1.46, 95 % CI: 1.16-1.83; P = 0.011). Notably, the relative risk of AAV-related deaths increased over the study period (Z = 2.77, P < 0.01). AAV, particularly MPA, is associated with increased hospital mortality, particularly among older adults and patients with renal involvement.es_ES
dc.language.isoenges_ES
dc.publisherELSEVIERes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectANCA-associated vasculitis; Eosinophilic granulomatosis with polyangiitis; Epidemiology; Granulomatosis with polyangiitis; Microscopic polyangiitis; Mortalityes_ES
dc.subjectANCA-associated vasculitises_ES
dc.subjectEosinophilic granulomatosis with polyangiitises_ES
dc.subjectEpidemiologyes_ES
dc.subjectGranulomatosis with polyangiitises_ES
dc.subjectMicroscopic polyangiitises_ES
dc.subjectMortalityes_ES
dc.subject.meshHospitalization *
dc.subject.meshAged *
dc.subject.meshAdult *
dc.subject.meshHospital Mortality *
dc.subject.meshAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis *
dc.subject.meshHumans *
dc.subject.meshMiddle Aged *
dc.subject.meshRetrospective Studies *
dc.subject.meshLongitudinal Studies *
dc.titleEpidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016-2022)es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1016/j.autrev.2025.103863es_ES
dc.identifier.doi10.1016/j.autrev.2025.103863
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid40602701
dc.identifier.essn1873-0183
dc.journal.titleAutoimmunity Reviewses_ES
dc.volume.number24es_ES
dc.issue.number9es_ES
dc.page.initial103863es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decshospitalización *
dc.subject.decsadulto *
dc.subject.decsmortalidad hospitalaria *
dc.subject.decsvasculitis asociada a anticuerpos anticitoplasma de neutrófilos *
dc.subject.decshumanos *
dc.subject.decsanciano *
dc.subject.decsestudios longitudinales *
dc.subject.decsmediana edad *
dc.subject.decsestudios retrospectivos *


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional